In response to a May 28 hearing focused on revisions to Division 62 of the Oregon Board of Pharmacy’s policy on pharmaceuticals, IWLA submitted comments to clarify the unique role […]
The March 26 California State Board of Pharmacy Enforcement and Compounding Committee meeting focused on the latest iteration of the drafted regulations (Attachment 7 from above link) for third-party logistics […]
The U.S. Food and Drug Administration issued guidance for the Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, and Prescription Drugs. The document establishes initial […]
The U.S. Food and Drug Administration (FDA) is sticking to its timeline for implementation of the Drug Quality and Security Act (DQSA). According to IWLA Washington Representative Pat O’Connor: The […]
The U.S. Food and Drug Administration recently released recommendations in question-and-answer format for the purposes of clarifying the Drug Quality Security Act. However, several contradictions in the state and federal […]
In a letter sent Sept. 9, U.S. Representative Fred Upton (R-Mich.), chairman of the House Committee on Energy and Commerce and author of the U.S. Food and Drug Administration (FDA) […]
IWLA has been closely engaging the California Board of Pharmacy after issuance of AB 2605, a statewide pharmaceutical licensing requirement on third-party logistics providers. IWLA members fully support licensing standards […]
The U.S. Food and Drug Administration is hosting a public workshop focused a critical part of the Drug Quality and Security Act. The “Standards for the Interoperable Exchange of Information for […]
The California Assembly Committee passed AB 2605 on April 29. The bill imposes a statewide licensing requirement on third-party logistics providers in the pharmaceutical supply chain. The legislation is inconsistent with […]
California Assemblywoman Susan Bonilla intends to introduce legislation in the state that is designed to override federal licensing of 3PLs in the U.S. Food and Drug Administration Drug Quality and […]
iwla1891 